New warnings added to US group's drug safety site

Key points
- Consumer watchdog group Public Citizen expanded its drug safety Web site worstpills.org on Wednesday to include more warnings about side effects, drug interactions and inadequate research.
- The safety warnings and recommendations on more than 500 products include 181 drugs that Public Citizen says patients should not use despite U.S.
- Neither "the FDA nor the industry are putting out really accurate information," said Public Citizen's Health Research Group Director Dr.
- The worstpills site expansion follows several months of warnings by companies and regulators about prescription and over-the-counter painkillers that were shown to increase the risk of heart attacks and strokes.
Consumer watchdog group Public Citizen expanded its drug safety Web site worstpills.org on Wednesday to include more warnings about side effects, drug interactions and inadequate research.
The safety warnings and recommendations on more than 500 products include 181 drugs that Public Citizen says patients should not use despite U.S. Food and Drug Administration approval.
Neither "the FDA nor the industry are putting out really accurate information," said Public Citizen's Health Research Group Director Dr. Sidney Wolfe, who in the past has cautioned about drugs before they were withdrawn or required additional safety label warnings.
The worstpills site expansion follows several months of warnings by companies and regulators about prescription and over-the-counter painkillers that were shown to increase the risk of heart attacks and strokes.
Merck & Co. Inc. pulled its arthritis drug Vioxx from the market in September. Last month the National Institutes of Health halted two studies involving Pfizer Inc.'s Celebrex and naproxen, sold by Bayer AG under the brand name Aleve.
The FDA has also cautioned patients and doctors to limit their use of such drugs and will hold a meeting next month to discuss them.
Wolfe said his group first noted concerns over Vioxx in 2001 and included them in earlier versions of the book.
Of the 181 drugs, which include Vioxx, Pfizer painkillers Celebrex and Bextra are a top concern, Wolfe said. The group plans to petition the FDA as early as next week to remove both drugs from the market, he said.
Court Rosen, spokesman for the industry group Pharmaceutical Research and Manufacturers of America, said patients were welcome to research their medicines but should not stop taking a drug without talking to their doctors.
Rosen added that the FDA was "the best in the world" at evaluating medicines and that patients should be confident that their drugs are safe.
But Wolfe said that that is not always the case. "Drugs that shouldn't get on the market, get on the market" and others that show problems after approval continue to be sold, he said.
Doctors and patients are also misled by direct-to-consumer advertising that downplays side effects, and they need another place to get warning information, Wolfe added.
About 100,000 Americans die each year from drug reactions, and most are preventable, Wolfe said.
Patients who don't subscribe to the Web site can still find basic warning information, he said. Users can also look up side effects and find medicines that can cause them.
The site has information for the first time on dietary supplements, including black cohosh, ginseng, saw palmetto and 10 others - all of which the group cautions against using to treat medical conditions.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsTherapy Free of Side Effects of Other HCV Drugs
An investigational protease inhibitor (PI) led to viral cures in about four out of five hepatitis C virus (HCV) patients, a researcher reported here. In a phase III study, either of two doses of faldaprevir combined…
26 April 2013
NewsGenes reveal which patients will benefit from scleroderma drug
Systemic sclerosis, also known as scleroderma, is a rare autoimmune connective tissue disorder that's difficult to treat. However, thanks to new research at Northwestern University Feinberg School of Medicine and…
11 April 2013
NewsPopular antibiotic Zithromax may cause heart rhythm problems, warns U.S. drug regulator
A popular antibiotic used to treat a variety of infections may cause a potentially fatal heart rhythm problem in some patients. Azithromycin, also known under its brand name Zithromax, is prescribed for infections of…
